Industry News: Nutra Pharma Announces Nyloxin Rx, A Prescription Analgesic For The Treatment Of Severe (Stage 3) Chronic Pain

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain

In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits PL Intelligence has to offer. Find out more.

Request a demo of
PL Intelligence

Company details

If you want to find out more about the company visit Nutra Pharma profile.

Related news

Latest News

Tobira Therapeutics Inc. Announce Presentation of TBR-652 Data at European AIDS Conference

Theratechnologies presents combined Phase 3 clinical results at European AIDS Conference

Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury

Simcyp Simulator aids in preclinical ADME assessment of Genentech compound

AlphaVax Progresses a Prophylactic HSV Vaccine

ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care

ORTHO CLINICAL DIAGNOSTICS LAUNCHES FETALSCREEN(TM) II FETAL MATERNAL HEMORRHAGE SCREENING TEST

PRIMA BIOMED SECURES JAPANESE PATENT FOR CANCER VAC

Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris

Two new appointments to BioAlliance Pharma's Supervisory Board in phase with the company's development

More news... | RSS Feed...

Most Viewed

Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris

Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data at the IDF's 20TH World Diabetes Congress

Two new appointments to BioAlliance Pharma's Supervisory Board in phase with the company's development

Tobira Therapeutics Inc. Announce Presentation of TBR-652 Data at European AIDS Conference

PRIMA BIOMED SECURES JAPANESE PATENT FOR CANCER VAC

Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference

BioAlliance Pharma announces Phase I trial for Fentanyl Lauriad

Simcyp Simulator aids in preclinical ADME assessment of Genentech compound

Tarix Pharmaceuticals receives IND to treat HIV patients with persistently low CD4 counts

ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain

Company details

Related news

Latest News

Most Viewed

Therapeutic Target

Categories